MyAverix Finance
SHE · Healthcare
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246)
Drug Manufacturers - Specialty & Generic
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $9.20B, P/E ratio is 575.25, net margin is 0.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301246
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) — FAQ
What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A's market cap?
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) has a reported market cap of $9.20B (data as of 2026-03-29).
What is 301246's P/E ratio?
The price-to-earnings (P/E) ratio for Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) is 575.25 (data as of 2026-03-29).
Does Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246). Check the MyAverix Finance app for the latest dividend data.
What sector is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A in?
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301246 listed on?
301246 is listed on SHE.
What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A's net margin?
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) reports a net margin of 0.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.